Muraglitazar

• Description:

  Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα and PPARγ with EC50 of 320 nM and 110 nM respectively.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  516.54

• Molecular Formula:

  C29H28N2O7

• Notes:

  Research use only, not for human use.

• Receptor:

  PPAR

• CAS Number:

  331741-94-7